This presentation introduces you to Myositis Specific Antibodies or MSAs and addresses important questions, including the following:
How are MSAs tested, and what is their value?
How have myositis-specific antibodies improved our understanding of myositis by identifying clinical patterns that help doctors understand how the disease might progress in patients with certain MSAs?
What is the value of understanding MSAs to help further personalize treatment options that your clinical team may consider?
Con:
Sara Sabbagh, D.O., is a clinician scientist who specializes in the care and research of patients with juvenile myositis. Upon completion of fellowship at the Children’s National Medical Center in Washington, D.C. and the National Institutes of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases, Dr. Sabbagh received specialized training in juvenile myositis assessments under the direction of Dr. Lisa Rider at the National Institute of Environmental Health Sciences, NIH. She also held an affiliate faculty appointment at George Washington University, where she saw juvenile myositis patients at the Medical Faculty Associates Myositis Center, Centro de Excelencia Cure JM.
